Literature DB >> 17986521

An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda.

Ivana Barbaric1, Mark J Perry, T Neil Dear, Alexandra Rodrigues Da Costa, Daniela Salopek, Ana Marusic, Tertius Hough, Sara Wells, A Jackie Hunter, Michael Cheeseman, Steve D M Brown.   

Abstract

The mechanisms that regulate bone mass are important in a variety of complex diseases such as osteopenia and osteoporosis. Regulation of bone mass is a polygenic trait and is also influenced by various environmental and lifestyle factors, making analysis of the genetic basis difficult. As an effort toward identifying novel genes involved in regulation of bone mass, N-ethyl-N-nitrosourea (ENU) mutagenesis in mice has been utilized. Here we describe a mouse mutant termed Yoda that was identified in an ENU mutagenesis screen for dominantly acting mutations. Mice heterozygous for the Yoda mutation exhibit craniofacial abnormalities: shortened snouts, wider skulls, and deformed nasal bones, underlined by altered morphology of frontonasal sutures and failure of interfrontal suture to close. A major feature of the mutant is reduced bone mineral density. Homozygosity for the mutation results in embryonic lethality. Positional cloning of the locus identified a missense mutation in a highly conserved region of the ankyrin repeat domain 11 gene (Ankrd11). This gene has not been previously associated with bone metabolism and, thus, identifies a novel genetic regulator of bone homeostasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986521     DOI: 10.1152/physiolgenomics.00116.2007

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  22 in total

1.  Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Authors:  Jennifer Johnston; Yudith Ramos-Valdes; Lee-Anne Stanton; Sadia Ladhani; Frank Beier; Gabriel E Dimattia
Journal:  Transgenic Res       Date:  2010-02-20       Impact factor: 2.788

2.  Mutations in ANKRD11 cause KBG syndrome, characterized by intellectual disability, skeletal malformations, and macrodontia.

Authors:  Asli Sirmaci; Michail Spiliopoulos; Francesco Brancati; Eric Powell; Duygu Duman; Alex Abrams; Guney Bademci; Emanuele Agolini; Shengru Guo; Berrin Konuk; Asli Kavaz; Susan Blanton; Maria Christina Digilio; Bruno Dallapiccola; Juan Young; Stephan Zuchner; Mustafa Tekin
Journal:  Am J Hum Genet       Date:  2011-07-21       Impact factor: 11.025

3.  Characterization of ANKRD11 mutations in humans and mice related to KBG syndrome.

Authors:  Katherina Walz; Devon Cohen; Paul M Neilsen; Joseph Foster; Francesco Brancati; Korcan Demir; Richard Fisher; Michelle Moffat; Nienke E Verbeek; Kathrine Bjørgo; Adriana Lo Castro; Paolo Curatolo; Giuseppe Novelli; Clemer Abad; Cao Lei; Lily Zhang; Oscar Diaz-Horta; Juan I Young; David F Callen; Mustafa Tekin
Journal:  Hum Genet       Date:  2014-11-21       Impact factor: 4.132

4.  A hearing and vestibular phenotyping pipeline to identify mouse mutants with hearing impairment.

Authors:  Rachel E Hardisty-Hughes; Andrew Parker; Steve D M Brown
Journal:  Nat Protoc       Date:  2010-01-07       Impact factor: 13.491

5.  Identification of ANKRD11 and ZNF778 as candidate genes for autism and variable cognitive impairment in the novel 16q24.3 microdeletion syndrome.

Authors:  Marjolein H Willemsen; Bridget A Fernandez; Carlos A Bacino; Erica Gerkes; Arjan P M de Brouwer; Rolph Pfundt; Birgit Sikkema-Raddatz; Stephen W Scherer; Christian R Marshall; Lorraine Potocki; Hans van Bokhoven; Tjitske Kleefstra
Journal:  Eur J Hum Genet       Date:  2009-11-18       Impact factor: 4.246

Review 6.  The old and new face of craniofacial research: How animal models inform human craniofacial genetic and clinical data.

Authors:  Eric Van Otterloo; Trevor Williams; Kristin Bruk Artinger
Journal:  Dev Biol       Date:  2016-01-22       Impact factor: 3.582

Review 7.  Prioritizing the development of mouse models for childhood brain disorders.

Authors:  Kevin K Ogden; Emin D Ozkan; Gavin Rumbaugh
Journal:  Neuropharmacology       Date:  2015-07-29       Impact factor: 5.250

8.  Comprehensive analysis of clinical spectrum and genotype associations in Chinese and literature reported KBG syndrome.

Authors:  Qiuyue Li; Chengjun Sun; Lin Yang; Wei Lu; Feihong Luo
Journal:  Transl Pediatr       Date:  2021-04

9.  A mouse model of early-onset renal failure due to a xanthine dehydrogenase nonsense mutation.

Authors:  Sian E Piret; Christopher T Esapa; Caroline M Gorvin; Rosie Head; Nellie Y Loh; Olivier Devuyst; Gethin Thomas; Steve D M Brown; Matthew Brown; Peter Croucher; Roger Cox; Rajesh V Thakker
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

10.  Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation.

Authors:  Kenny Man; Mathieu Y Brunet; Maria Fernandez-Rhodes; Soraya Williams; Liam M Heaney; Lee A Gethings; Angelica Federici; Owen G Davies; David Hoey; Sophie C Cox
Journal:  J Extracell Vesicles       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.